The binding of TRAIL to its cognate receptors enables a plethora of cellular responses that can either contribute to tumor immunosurveillance or tumor development and metastasis in a cancer context-dependent manner [2,3,4]. The gene discussed is TNFSF10; the disease is neoplasm.